[Effect of Lioresal in spasticity].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000613:Aminobutyrates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001927:Brain Diseases / Q000503:physiopathology; D004576:Electromyography; D005260:Female; D006429:Hemiplegia / Q000503:physiopathology; D006801:Humans; D008297:Male; D008526:Medulla Oblongata / Q000503:physiopathology; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000503:physiopathology; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011312:Pressure; D012023:Reflex, Monosynaptic; D013035:Spasm / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
D000613:Aminobutyrates; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics
Etude de l'effet du Liorésal dans la spasticité.